Table 5 Effects of pre-vaccination.
From: Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm
Country | Relative reduction in epidemic size, %a | ||
|---|---|---|---|
| Â | Pre-vaccination 20% | Pre-vaccination 30% | Pre-vaccination 50% |
China | 27.3 to 28.2 | 46.3 to 48.2 | 98.9 to 99.3 |
Hungary | 23.2 to 24.4 | 38.6 to 39.2 | 87.9 to 90.0 |
United States | 20.5 to 21.8 | 35.2 to 36.2 | 92.4 to 95.5 |
Canada | 21.5 to 22.6 | 37.5 to 38.3 | 93.4 to 95.6 |
Italy | 23.0 to 24.4 | 38.3 to 39.0 | 90.2 to 91.8 |
Japan | 23.4 to 26.8 | 38.1 to 40.1 | 85.5 to 89.8 |
Israel | 22.9 to 24.8 | 37.8 to 38.8 | 84.3 to 86.4 |
France | 22.0 to 24.2 | 36.6 to 38.1 | 84.4 to 86.8 |
Sweden | 23.1 to 24.8 | 38.2 to 39.0 | 86.3 to 88.6 |
UK | 22.2 to 24.6 | 36.6 to 38.4 | 84.7 to 88.4 |
Germany | 22.6 to 24.2 | 37.7 to 38.6 | 88.9 to 90.6 |
Portugal | 22.7 to 24.5 | 37.1 to 38.6 | 88.3 to 92.4 |
Finland | 22.9 to 24.7 | 37.7 to 38.7 | 84.5 to 87.3 |
Austria | 21.6 to 23.5 | 35.8 to 37.1 | 81.7 to 84.1 |
Ireland | 22.0 to 24.0 | 36.2 to 37.6 | 83.0 to 86.6 |
Denmark | 21.5 to 23.5 | 35.6 to 37.1 | 81.7 to 85.0 |
Turkey | 26.5 to 27.0 | 46.4 to 49.6 | 95.4 to 95.8 |
Iceland | 20.6 to 24.8 | 33.9 to 38.6 | 78.8 to 87.8 |
Belgium | 23.2 to 24.8 | 38.6 to 39.4 | 89.1 to 91.1 |
Slovenia | 21.5 to 23.3 | 35.3 to 36.8 | 76.4 to 81.1 |
Netherlands | 21.7 to 24.7 | 36.3 to 38.4 | 85.5 to 89.5 |
Switzerland | 21.0 to 24.0 | 34.4 to 36.8 | 77.5 to 81.9 |
Spain | 22.4 to 23.7 | 37.7 to 39.0 | 91.7 to 93.7 |
Greece | 23.2 to 24.8 | 38.6 to 39.5 | 86.1 to 87.7 |
Tunisia | 24.5 to 25.7 | 41.0 to 42.1 | 90.9 to 92.0 |
Czech Republic | 24.8 to 25.6 | 42.0 to 44.9 | 89.7 to 90.6 |
Norway | 23.1 to 24.7 | 37.9 to 38.9 | 85.9 to 88.7 |